Fundraising FoxAltitude Ventures Management, Llc
Venture capitalKirkland · Seed–Series A · 3 people tracked
Find your way into Altitude Ventures Management, Llc
Sign up to see every warm intro you have to Altitude Ventures Management, Llc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Altitude Ventures Management, Llc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Altitude focuses on early-stage life science companies across a broad range of technologies rooted in advances in biology or chemistry, including therapeutics, diagnostics, gene editing, AI/ML therapeutics, autonomous science, medical devices, dermatology, drug delivery platforms, industrial and chemical applications, and DNA sequencing. The firm differentiates itself through intellectual property strategic planning, drawing on deep IP experience to conduct extended due diligence and complement syndicate partners. Its approach integrates the development and presentation of a company's IP portfolio to preserve competitive advantages, protect near- and long-term product opportunities, support R&D and business development, and ultimately maximize the perceived and demonstrated value of the company's technology as it matures toward a liquidity event.
Source: firm website, verified Sep 29, 2026.
Team · 3 people
from public directories
What they invest in
from 10 of 12 portfolio companiesBiotech ×10Deep Tech ×7AI & Machine Learning ×4Medical Devices ×4Digital Health ×1Healthtech ×1Longevity ×1SaaS ×1
HQs:United States×6
Investments · 12 tracked
founders shown can be your intro path
Generate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering.
AI & Machine LearningBiotechDeep TechSomerville, US
Gevorg Grigoryan(Founder)inMichael Nally(Chief Executive Officer)inAvak Kahvejian(Founder)Geoffrey von Maltzahn(Founder)Molly Gibson(Founder)
Co-investorsFlagship PioneeringAlumni VenturesARCH Venture PartnersMarch Capital PartnersNVIDIAAlaska Permanent Fund Corporation+4 more
Aera Therapeutics develops genetic medicines using next-generation delivery technologies and precision payloads optimized for specific diseases.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
Feng Zhang, Ph.D.(Scientific Founder & Board Observer)Akin Akinc, Ph.D.(Chief Executive Officer & Board Director)Akin Akinc(Founder)Feng Zhang(Founder)Feng Zhang Akin Akinc(Founder)John Maraganore(Founder)
Co-investorsARCH Venture PartnersLux CapitalF-Prime CapitalGV (Google Ventures)JDRF T1D FundNewpath Partners
Altos Labs develops computational and scientific approaches to reverse disease through breakthrough medicines, operating research institutes focused on cell health, computation, and drug discovery.
BiotechDeep TechLongevityBay Area, US
Richard Murray(CEO and Founder)Shinya Yamanaka(Founder)Hal Barron(CEO and Founder)inRichard Klausner(Founder)Hans Bishop(Founder)Juan Carlos Izpisua Belmonte(Founder)in
Co-investors8VCARCH Venture PartnersGeneral CatalystLuma Group
.png)
Ansa provides an enzymatic DNA synthesis platform that directly synthesizes complex sequences up to 900 bp and delivers constructs up to 50 kb without assembly-based methods.
BiotechDeep TechHealthtechEmeryville, US
Dan Lin-Arlow(Founder)inSebastian Palluk(Founder)inDaniel Hillel Lin-Arlow(Executive Officer, Director)Jason T. Gammack(Executive Officer, Director)inDaniel Lin-Arlow(Founder)Jared Ellefson(Founder)
Co-investorsCarbon SiliconCerberus VenturesDauntless VenturesFifty YearsJude GomilaMetaplanet+12 more
Developing microscale robots to deliver therapies locally to targeted brain disease areas.
Co-investorsAlumni VenturesBlue Ivy VenturesBold Capital PartnersCompoundDeep InsightDolby Family Ventures+9 more
City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.
BiotechMedical DevicesCambridge, US
Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in
Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesViking GlobalCasdin CapitalFidelity Investments+5 more
Interdict Bio develops orally bioavailable small molecules called Interdictors that inhibit ribosomal protein synthesis in a context-dependent manner to target historically undruggable proteins.
BiotechDeep Tech
Larry Hamann(Founder)
Co-investorsVenrock
LILA Sciences builds AI systems for autonomous scientific research and discovery across medicine, materials, energy, and defense sectors.
AI & Machine LearningBiotechDeep TechSaaS
Geoffrey von Maltzahn(CEO)Molly Gibson(Founder)Noubar Afeyan(Founder)
Co-investorsAlumni VenturesCatalio Capital Management, LPDauntless VenturesFlagship PioneeringGeneral CatalystIn-Q-Tel+9 more
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)in
Co-investorsARCH Venture PartnersJDRF T1D FundMRL Ventures FundOno Venture Investment, Inc.Pfizer Venture InvestmentsSofinnova Partners+6 more
Tessera Therapeutics develops Gene Writing, a genome engineering technology platform designed to make permanent alterations to the human genome for treating diseases.
BiotechDigital HealthMedical Devices
Geoff von Maltzahn(Founder)inJoseph Romanelli(CEO)Geoffrey von Maltzahn(Founder)Jacob Rubens(Founder)Noubar Afeyan(Founder)Rob Citorik(Founder)
Co-investorsArtis VenturesFlagship PioneeringMarch Capital PartnersOMX VenturesSoftBank Vision FundSolari Capital+5 more
Vilya designs novel macrocycles using AI and computational biology to create medicines that don't exist in nature.
AI & Machine LearningBiotechDeep Tech
David Baker(Founder)Patrick Salveson, PhD(Co-Founder, CTO)Adam Moyer, PhD(Co-Founder, VP of Molecular Design)David Baker, PhD(Nobel laureate, Co-Founder, Director, IPD UW, Prof. Biochemistry)Gaurav Bhardwaj, PhD(Co-Founder, UW, Asst. Prof. Medicinal Chemistry)Lance Stewart, PhD, MBA(Co-Founder, CSO & COO, IPD)
Co-investorsARCH Venture PartnersMadrona Venture GroupMenlo VenturesNVIDIAAlumni VenturesAtomic+10 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Sail Biomedicines
Exits · 1
1 IPOsGenerate BiomedicinesNASDAQ: GENB
Portfolio news
latest coverage across their companiesCity Therapeutics · finsmes.com · Jun 9, 2026
Lila Sciences · finsmes.com · Jun 4, 2026
Ansa Biotechnologies · finsmes.com · Oct 2, 2025
Frequently asked questions
- How many investments has Altitude Ventures Management, Llc made?
- Altitude Ventures Management, Llc has 12 tracked investments, 1 of which have exited.
- What stage does Altitude Ventures Management, Llc invest at?
- Altitude Ventures Management, Llc invests at the Seed, Series A stages.
- What sectors does Altitude Ventures Management, Llc focus on?
- Altitude Ventures Management, Llc focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Medical Devices, Robotics.
- Where is Altitude Ventures Management, Llc located?
- Altitude Ventures Management, Llc is headquartered in Kirkland, US.
Co-investors · 4
ARCH Venture Partners is a venture capital firm that invests in and helps build transformational companies, with a strong focus on the life sciences and biotechnology sector.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.
5AM Ventures is a life science venture capital firm founded in 2002 that funds and builds next-generation life sciences companies, focusing on biopharmaceuticals, drug delivery technologies, and life science instruments.
Firms observed investing alongside Altitude Ventures Management, Llc, from public investor directories. Shared companies are the overlap with Altitude Ventures Management, Llc's recorded portfolio.
Similar investors
Serra Ventures is an early-stage venture capital firm that also provides M&A advisory and consulting services to middle-market companies, with a strong focus on ag and food technology.
EMV Capital is a deep tech and life sciences venture capital investment group that invests in, strengthens, and manages early-stage companies with attractive intellectual property. It uses a capital-efficient model combining syndicated investments, balance sheet stakes, and fund deployment.
Asia2G (A2G) Capital is a Silicon Valley venture capital firm that invests primarily in early-stage Korean and Asian technology startups seeking to expand globally.
Bayern Kapital is a public venture capital and growth investor backing innovative Bavarian high-tech, deep tech and life sciences start-ups and scale-ups, acting as an anchor investor across multiple funding rounds.
Artesian is a deep tech and hardware venture capital investor that builds funds around specific institutional backers — governments, corporations, universities, industry bodies and super funds — to pursue both financial returns and strategic outcomes in critical industries.